Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today presented new in vitro data at Digestive Disease Week (DDW) showing plecanatide, an investigational ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE